The 92nd edition of API China successfully wrapped up recently reaffirming its role as a cornerstone event for the pharmaceutical, health, and nutrition industries. Held at the China Import and Export ...

Strong growth is projected for the pharmaceutical industry in China, offering opportunities for drug companies and manufacturers of active pharmaceutical ingredients. The global pharmaceutical market ...

Wuxi STA, a subsidiary of WuXi AppTec, continued its manufacturing expansion march with the opening of another high-potency active pharmaceutical ingredient (HPAPI) production facility in China. The ...

In his latest article, Ames Gross explores the opportunities for pharma in China's API market. The active pharmaceutical ingredient (API) market in Asia is worth $32.5 billion, and it is growing ...

China on Thursday issued guidelines aimed at stamping out monopolies in the active pharmaceutical ingredients (API) market, saying that such behaviour had become common. Adds details, context BEIJING, ...

European authorities have decided to block the amoxicillin trihydrate API produced by a company in China, whose manufacturing quality oversight has been found to be weak. The steps against Inner ...